[Anakinra treatment in refractory systemic onset juvenile arthritis]

An Pediatr (Barc). 2008 Mar;68(3):305-6. doi: 10.1157/13116717.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Male
  • Pain, Intractable

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein